Cargando…
Quinol derivatives as potential trypanocidal agents
Quinols have been developed as a class of potential anti-cancer compounds. They are thought to act as double Michael acceptors, forming two covalent bonds to their target protein(s). Quinols have also been shown to have activity against the parasite Trypanosoma brucei, the causative organism of huma...
Autores principales: | Capes, Amy, Patterson, Stephen, Wyllie, Susan, Hallyburton, Irene, Collie, Iain T., McCarroll, Andrew J., Stevens, Malcolm F.G., Frearson, Julie A., Wyatt, Paul G., Fairlamb, Alan H., Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281193/ https://www.ncbi.nlm.nih.gov/pubmed/22264753 http://dx.doi.org/10.1016/j.bmc.2011.12.018 |
Ejemplares similares
-
Antitumor Quinol PMX464 Is a Cytocidal Anti-trypanosomal Inhibitor Targeting Trypanothione Metabolism
por: König, Janine, et al.
Publicado: (2011) -
Discovery of a Novel Class
of Orally Active Trypanocidal N-Myristoyltransferase
Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011) -
Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011) -
Design and Synthesis
of Brain Penetrant Trypanocidal N-Myristoyltransferase
Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017) -
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)